Delayed Bleeding
Conditions
Brief summary
after endoscopic submucosal dissection(ESD) of early gastric cancer, conventional proton pump(PPI) inhibitors and H2 receptor antagonists have a controversial effect on preventing bleeding from artificial ulcers. the aim of this study was to investigate whether a stronger acid suppression (high dose PPI) more effectively prevents bleeding after ESD
Interventions
IV loading PPI before 2hr to conduct ESD, and IV 8mg/h continuous infusion within 48hr, and then 40mg oral pantoprazole for one month
IV 50mg loading H2 receptor antagonist before 2hr to conduct ESD, and IV 13mg/h continuous infusion within 48hr, and then 300mg oral H2 receptor antagonist for one month
Sponsors
Study design
Eligibility
Inclusion criteria
* the patients who agreed informed consent * gastric adenoma or early gastric cancer which is eligible for conventional ESD indication
Exclusion criteria
* recent drug history of PPI, H2 rector antagonist, bismuth and antibiotics within 4 weeks * recent drug history of anticoagulant or antiplatelet agent within 7 days * s/p subtotal gastrectomy * recurred gastric adenoma or cancer * pregnant or breast feeding patients
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| bleeding incidence after ESD | time to occur delayed bleeding within one month after ESD |
Secondary
| Measure | Time frame |
|---|---|
| the size of healing ulcer after ESD | follow up endoscopy for the healing of iatrogenic ulcer after one month ESD |
Countries
South Korea